Revenue grew modestly 16.5% to $9.1M as biomedical product sales gains offset anti-aging skincare weakness, but gross profit declined 4.8% to $5.1M due to higher production costs, widening operating and net losses amid ongoing cash management efforts.
Revenue breakdown: Biomedical Market (96%), Anti Aging Skincare Market (2%), Anti Aging Market (2%).
—
Market Cap
—
Revenue
—
Net Income
Revenue by Segment
Revenue by Geography
No significant events in the past 90 days.